Thomas F. Rocereto

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 634 citations · Full text

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus☆

Aaron H. Wolfson, M. Brady, Thomas F. Rocereto et al. · Gynecologic Oncology · 2007 · 257 citations · Full text

Whole Abdominal Irradiation, Surgical Oncology, Radiation Medicine +11

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study

Sarah T. Lincoln, John A. Blessing, Roger B. Lee et al. · Gynecologic Oncology · 2003 · 172 citations

Oncology, Medicine, Cancer Management +9

Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma—a Gynecologic Oncology Group Study

Jeffrey D. Bloss, Mark F. Brady, Shu Liao et al. · Gynecologic Oncology · 2003 · 76 citations

Tumoral Pathology, Gynecological Surgery, Phase Ii Trial +6

Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers.

Sharon L. Manne, Stephen C. Rubin, Mitchell I. Edelson et al. · Journal of Consulting and Clinical Psychology · 2007 · 75 citations

Counseling, Cancer Management, Gynecology +20